Skip to main navigation
About Us
Our Company
Overview
Management Team
Board of Directors
Scientific Advisory Board
Partners & Collaborations
Contact
Our Pipeline
Pipeline
Overview
Azenosertib
ZN-d5
BCL-xL Degrader
Clinical Trials
Our Approach
Integrated Discovery Engine
Our advanced approach to efficiently identifying and developing novel oncology therapies.
Supporting Publications
Investors & Media
Investors & Media
Investor Home
News & Events
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Historic Price Lookup
Investment Calculator
Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Scientific Advisory Committee
Committee Composition
Investor Resources
Investor FAQs
Investor Contact
Email Alerts
Careers
Working at Zentalis
Be part of a vibrant team committed to our common goal: to better the lives of patients impacted by cancer.
Job Opportunities
Investors & Media
Press Releases
Investor Relations Menu
Investor Home
News & Events
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Historic Price Lookup
Investment Calculator
Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Scientific Advisory Board
Committee Composition
Investor Resources
Investor FAQs
Investor Contact
Email Alerts
Contact
Carlo Tanzi, Ph.D.
Kendall Investor Relations
ctanzi@kendallir.com
More news releases are coming soon.
